Principal Financial Group Inc Sorrento Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.74 - $1.83 $16,766 - $41,462	22,657 Added 27.13%	106,183 $94,000
Q3 2022 Nov 09, 2022	BUY	$1.51 - $2.88 $25,863 - $49,328	17,128 Added 25.8%	83,526 $131,000
Q2 2022 Aug 10, 2022	SELL	$1.24 - $2.33 $23,889 - $44,889	-19,266 Reduced 22.49%	66,398 $133,000
Q1 2022 May 09, 2022	BUY	$2.0 - $4.9 $3,228 - $7,908	1,614 Added 1.92%	85,664 $200,000
Q4 2021 Feb 09, 2022	SELL	$4.65 - $7.23 $123,978 - $192,766	-26,662 Reduced 24.08%	84,050 $391,000
Q3 2021 Nov 09, 2021	BUY	$7.41 - $10.99 $26,490 - $39,289	3,575 Added 3.34%	110,712 $845,000
Q2 2021 Aug 10, 2021	SELL	$6.35 - $10.0 $20,396 - $32,120	-3,212 Reduced 2.91%	107,137 $1.04 Million
Q1 2021 May 10, 2021	SELL	$7.03 - $16.51 $41,940 - $98,498	-5,966 Reduced 5.13%	110,349 $913,000
Q4 2020 Feb 08, 2021	BUY	$5.76 - $11.95 $267,575 - $555,125	46,454 Added 66.49%	116,315 $793,000
Q3 2020 Nov 06, 2020	BUY	$6.17 - $18.82 $24,445 - $74,564	3,962 Added 6.01%	69,861 $778,000
Q2 2020 Aug 05, 2020	BUY	$1.73 - $6.76 $50,507 - $197,358	29,195 Added 79.54%	65,899 $414,000
Q1 2020 May 12, 2020	BUY	$1.57 - $4.76 $1,155 - $3,503	736 Added 2.05%	36,704 $67,000
Q4 2019 Feb 05, 2020	BUY	$1.45 - $4.17 $5,840 - $16,796	4,028 Added 12.61%	35,968 $122,000
Q3 2019 Nov 13, 2019	BUY	$2.05 - $2.69 $7,765 - $10,189	3,788 Added 13.46%	31,940 $68,000
Q2 2019 Aug 12, 2019	SELL	$2.67 - $4.38 $127,810 - $209,666	-47,869 Reduced 62.97%	28,152 $75,000
Q1 2019 May 10, 2019	SELL	$1.86 - $5.94 $827 - $2,643	-445 Reduced 0.58%	76,021 $361,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $32,385 - $68,314	-16,112 Reduced 17.4%	76,466 $183,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $19,530 - $34,710	4,628 Added 5.26%	92,578 $408,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $417,762 - $703,600	87,950 New	87,950 $0

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account